Close menu




news.financial


Commented by Fabian Lorenz on November 18th, 2026 | 05:45 CET

50% Upside or Even a Multi-Bagger? A Look at Comeback Stocks: CTS Eventim, Standard Lithium and Antimony Resources

  • commodities
  • criticalrawmaterials
  • events
  • lithium
  • antimony

Created and published on behalf of Antimony Resources Corp.

Sharp corrections can create entry opportunities. But which stocks have the potential for a comeback? GBC Research sees potential for a severalfold increase in Antimony Resources and recommends buying the antimony explorer with a price target of EUR 1.60. Fresh capital can advance the development of the Canadian Bald Hill project. Standard Lithium has lost around 78% of its value since its January high. The market is waiting for project financing worth billions and remains unconvinced by the quarterly results. At CTS Eventim, the comeback is already underway. However, the quarterly results show that not everything is running smoothly. Nevertheless, analysts see share price upside of over 50%.

Read

Commented by Jens Castner on November 18th, 2026 | 05:40 CET

Treasures from the depths, a slump in the stock market: Lynas, Almonty and Cameco tempt with low share prices

  • Critical raw materials
  • Rare earths
  • Tungsten
  • Uranium
  • Almonty Industries
  • Cameco
  • AI
  • Lynas Rare Earths

Without rare earths, no electric motors; without tungsten, no defence industry; without uranium, no nuclear power. The West needs these raw materials more urgently than ever and depends on a handful of suppliers that mine in politically stable countries. Yet shares in Lynas Rare Earths, Almonty Industries and Cameco are falling as if there were no shortage – down by one-third to two-thirds from their highs for the year. We have taken a close look at the three producers following their latest quarterly results. One of the shares has reached bargain levels.

Read

Commented by Matthias Schomber on November 18th, 2026 | 05:36 CET

A three-way look: What Allianz shareholders, BioNTech investors and HPQ Silicon speculators should know now!

  • biotech
  • cancer drugs
  • cancer pipeline
  • coronavirus
  • vaccination
  • mrna
  • battery
  • rechargeable battery
  • rechargeable battery technology
  • battery cells
  • rechargeable battery cell
  • nanotechnology
  • drones
  • drone technology
  • insurance
  • insurance business

Created and published on behalf of HPQ Silicon
Allianz is delivering impressive record results. Vaccine specialist BioNTech continues to advance its oncology pipeline. Canadian small-cap HPQ Silicon may once again be on the verge of a promising technical breakout, as it was several years ago. Whether it is fundamental strength in the insurance sector, billion-dollar research bets in biotech and cancer drugs or speculative technology potential in batteries and energy storage, the following sections examine the opportunities, risks and financial data of these three very different stocks, providing investors with valuable guidance for their next strategic portfolio decisions.

Read

Commented by Matthias Schomber on November 18th, 2026 | 05:33 CET

Concerts, Gaming Hype Around GTA 6 and Gold Fever: Why CTS Eventim, Take-Two Interactive and DRC Gold Offer Opportunities

  • entertainment
  • ticketing
  • concerts
  • events
  • gta6
  • gaming
  • computer
  • ps5
  • xbox
  • gold
  • gold fever
  • gold rush
  • potential

Entertainment, gaming, commodities! These are what are moving the markets right now! Europe's ticketing king, CTS Eventim, is grappling with fears of a weaker concert business after its latest quarterly results. The entire gaming industry is watching intently as Take-Two Interactive prepares to launch GTA6, with sales likely to run into billions. Somewhat out of the spotlight, but still offering opportunities, a potential high-flyer is also taking shape at DRC Gold under the leadership of Klaus Eckhof in the shadow of the ongoing gold boom. We examine the hard financial data, operational opportunities and risks of these three stocks. Find out which price targets are possible, where the hurdles lie and which stock now offers bright prospects.

Read

Commented by Carsten Mainitz on November 18th, 2026 | 05:32 CET

Commodities, Steel and SpaceX: A Look at the Opportunities in Strategic Resources, thyssenkrupp and Singulus

  • Commodities
  • Iron ore
  • Pellets
  • Green steel
  • Vanadium
  • Titanium
  • Solar
  • Opportunities
  • Investments

A SpaceX order sends Singulus shares soaring. thyssenkrupp is driving forward its transformation into a pure financial holding company by spinning off materials distributor and service provider tk accelis and making the value of its holdings visible on the stock market. Strategic Resources, meanwhile, starts earlier in the industrial value chain. With high-purity iron ore pellets as well as vanadium, iron and titanium, the company aims to position itself as a raw materials supplier for lower-emission steel production and other future applications. Which share will come out ahead next year?

Read

Commented by Armin Schulz on November 18th, 2026 | 05:30 CET

Pharma Turnaround Stocks Under Review: Evotec, Vidac Pharma and Novo Nordisk – Restructuring, Clinical Trial Results and Outlook

  • Evotec
  • Vidac Pharma
  • Novo Nordisk
  • Drug discovery
  • Biotech
  • Pharma
  • Cancer
  • Oncology
  • Warburg effect
  • Obesity
  • Diabetes
  • Weight-loss pill

Between November 4 and 9, three pharma and biotech stocks released news that suggests a turning point. At one, the quarterly loss before exceptional items narrowed; at the second, initial data from a placebo-controlled trial are available; and the third has raised its full-year guidance. These are not yet proof of a lasting turnaround, but they are verifiable signs of progress. If this trajectory can be maintained, hope could soon turn into substance. We therefore take a closer look at Evotec, Vidac Pharma and Novo Nordisk to see which has turnaround potential.

Read

Commented by Fabian Lorenz on November 18th, 2026 | 05:29 CET

Horror at Plug Power! Verbio with a jump in profits! dynaCERT on the verge of a breakthrough?

  • commodities
  • energy
  • hydrogen
  • efficiency

Will Plug Power shares fall below USD 1? It certainly looks as though the horror at the former hydrogen favourite is not over. The latest quarterly figures have not provided any positive momentum. At the same time, the valuation remains above USD 1 billion. At dynaCERT, pilot projects are expected to turn into major orders in the coming months. The German management is optimistic and points to the profitability of its technology for customers. The company aims to reduce the fuel consumption and emissions of existing diesel engines. Verbio has sharply increased its quarterly EBITDA. Analysts expect margins to continue rising and recommend buying the shares.

Read

Commented by Nico Popp on November 18th, 2026 | 05:28 CET

Copper at a crossroads: BHP produces less, Siemens Energy reports record orders – and Power Metallic Mines positions itself for growth

  • Copper
  • Data centres
  • Market
  • Electrification

Created and published on behalf of Power Metallic Mines

Copper is becoming cheaper, even though the major mines are supplying less and grid equipment suppliers are reporting record orders. How does that add up? On the London Metal Exchange, the price of the red metal temporarily fell to around USD 13,515 per tonne on November 13, its lowest level since July. Goldman Sachs sees the main reason as investor positioning around AI stocks, not weaker physical demand. The bank therefore considers its forecast of USD 15,400 per tonne for 2027 potentially too high and sees USD 14,500 to 14,600 per tonne as more likely. A different picture emerges in industry: major mine operators are producing less because ore grades are declining and accidents or strikes are slowing extraction. At the same time, power grid equipment suppliers are reporting record orders. A high-grade copper deposit in Canada aims to fill this gap between falling mine supply and rising demand.

Read

Commented by Armin Schulz on November 17th, 2026 | 19:35 CET

Bayer, Cardiol Therapeutics, Novartis – Biotech stocks and pharmaceutical giants in the race for the heart

  • Bayer
  • Cardiol Therapeutics
  • Novartis
  • Heart disease
  • Asundexian
  • Pharma
  • Pericarditis
  • CardiolRx
  • Leqvio

Created and Published on Behalf of Cardiol Therapeutics

Cardiology is one of the most exciting fields in the pharmaceutical industry. Four days in Chicago have shown just how much is happening in cardiovascular medicine. From November 6 to 9, pharmaceutical giants and small biotech companies gathered at the American Heart Association Scientific Sessions annual congress with a shared goal: to improve care for patients with cardiovascular disease. The major players bring experience and capital, while smaller companies often contribute fresh ideas. When a company succeeds in securing regulatory approval, investors stand to benefit. This interplay is precisely what makes the market so interesting for investors. We therefore take a closer look at Bayer, Cardiol Therapeutics, and Novartis.

Read

Commented by Armin Schulz on November 17th, 2026 | 05:44 CET

CTS Eventim, Aspermont, SAP – Opportunities in the AI age with tickets, mining data and software

  • CTS Eventim
  • Aspermont
  • Ticket sales
  • digital business
  • Artificial intelligence
  • Specialist publisher
  • Commodities
  • Mining data
  • Marketing agency
  • ERP
  • Business software
  • Cloud
  • Agents
  • SAP

Artificial intelligence does not hit every business model equally hard. Activist investor Ananym Capital announced its investment in CTS Eventim on October 20 and considers the ticket marketer resilient to AI. Aspermont wants to unlock its 190-year-old mining archive, and ten major mining groups are set to work with it in initial trials from November. Companies wanting to use AI need reliable data. SAP reported on October 21 that contractually committed cloud revenues of EUR 24.1 billion are due over the next 12 months. We therefore take a closer look at CTS Eventim, Aspermont and SAP.

Read

Commented by Lars Winter on November 17th, 2026 | 05:41 CET

Zefiro Methane in Focus Following Results: Analysts See Potential for a Threefold Gain

  • Zefiro Methane
  • Methane emissions
  • Well remediation
  • Plants & Goodwin
  • Viking Well Service
  • Carbon credits
  • Isometric
  • Data centres
  • GBC Research
  • Quarterly results
  • Turnaround

Created and Published on Behalf of Zefiro Methane Corp.

Before the excavators arrive for a new data centre, the legacy of the past sometimes has to be cleared away first. Beneath American building plots lie many abandoned oil and gas wells that have long been out of use but can still leak methane. Zefiro Methane makes money by professionally plugging these legacy wells. The Canadian environmental specialist has secured a substantial order backlog, won new customers and expanded its fleet. Now the investments are expected to pay off. The latest quarterly results show initial progress, while the carbon credit business offers additional upside potential. We take a closer look at the hot stock in our news check following the latest developments.

Read

Commented by Stefan Bode on November 17th, 2026 | 05:40 CET

Opportunities, Risks and Key Levels – dynaCERT, Munich Re and secunet Security

  • dynaCERT
  • Munich Re
  • secunet
  • Ottobock
  • Wacker Neuson
  • Patrizia
  • Grenke

Strong revenues, declining margins, new growth areas and surprisingly resilient profits are back in focus. Three very different stocks show how quickly market expectations can change. While a technology stock comes under massive pressure after the release of its quarterly results, a cleantech company faces an operational stress test. An insurance heavyweight, by contrast, impresses despite a decline in profit. Orders, profitability and key technical levels now remain decisive.

Read

Commented by Jens Castner on November 17th, 2026 | 05:33 CET

Nvidia, Micron Technology, Power Metallic Mines and Rheinmetall in a sell-off: Who can turn things around?

  • AI
  • Semiconductors
  • Critical raw materials
  • Armaments
  • Data centres
  • Copper
  • Gold
  • Silver
  • Mining
  • Defence
  • Nvidia
  • Micron Technology
  • Power Metallic Mines
  • Rheinmetall
  • Platinum
  • Nickel

Created and Published on Behalf of Power Metallic Mines

A resignation, a sell-off, a shrug and a lowered forecast: four stocks have taken a heavy beating in recent weeks. At Nvidia, the founder stumbled over private affairs, while at Micron, doubts about the AI boom were enough. Power Metallic Mines is delivering good news, but the market is looking the other way. And Rheinmetall has disappointed investors with full order books but delayed revenues. All four share a large gap between their current share prices and analysts' targets. We take a closer look at the stocks.

Read

Commented by Tarik Dede on November 17th, 2026 | 05:32 CET

Royalty stocks in focus: Franco-Nevada, RE Royalties and Brookfield Renewable Partners

  • Royalties
  • Dividends
  • Sustainability
  • Gold
  • Silver
  • Wind power
  • Solar

Interest rates are the most important factor for many royalty companies and dividend stocks. When long-term investors can earn high interest payments on government bonds, this often weighs on precisely these stocks. For companies that regularly refinance in the market, this becomes an additional burden. This is because borrowing costs then rise. However, a volatile environment like the current one also offers opportunities for equity investors. That is why today we are looking at the shares of Franco-Nevada, RE Royalties and Brookfield Renewable Partners.

Read

Commented by Stefan Feulner on November 17th, 2026 | 05:28 CET

Lithium Americas, Rock Tech Lithium, Albemarle – Between falling prices and mega-investments

  • Electromobility
  • critical raw materials

The lithium market is under pressure once again. Falling commodity prices are coinciding with investment programmes worth billions, while Europe and the US are seeking to reduce their dependence on Chinese supply chains. This is creating a dangerous balancing act for the industry. New mines and processing plants require enormous sums of capital, yet their economic viability depends on a market that remains difficult to predict. Companies with sufficient capital may be able to turn the crisis to their advantage. For smaller project developers, however, financing is becoming the decisive test.

Read